Optimization of TNF-α overexpression in Escherichia coli using response surface methodology: Purification of the protein and oligomerization studies.
暂无分享,去创建一个
[1] N. Nancib,et al. Variation and modeling of the probability of plasmid loss as a function of growth rate of plasmid‐bearing cells of Escherichia coli during continuous cultures , 1993, Biotechnology and bioengineering.
[2] A. Whitty,et al. Small-molecule inhibition of TNF-alpha. , 2005, Science.
[3] George Kollias,et al. A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF. , 2012, Human molecular genetics.
[4] A. Corti,et al. Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha. , 1995, Biochemistry.
[5] H. P. Sørensen,et al. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli , 2005 .
[6] F. Baneyx,et al. Expression of aggregation-prone recombinant proteins at low temperatures: a comparative study of the Escherichia coli cspA and tac promoter systems. , 1997, Protein expression and purification.
[7] M. Feldmann,et al. Development of anti-TNF therapy for rheumatoid arthritis , 2002, Nature Reviews Immunology.
[8] J. Thornton,et al. Structural characterisation and functional significance of transient protein-protein interactions. , 2003, Journal of molecular biology.
[9] G. Petersen,et al. Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins. , 2006, Protein expression and purification.
[10] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.
[11] J. Koehn,et al. High-Throughput Protein Production (HTPP): a review of enabling technologies to expedite protein production. , 2009, Methods in molecular biology.
[12] Jun Wang,et al. Small-Molecule Inhibition of TNF-α , 2005, Science.
[13] R. Rudolph,et al. In vitro folding of inclusion body proteins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] D. MacEwan. TNF receptor subtype signalling: differences and cellular consequences. , 2002, Cellular signalling.
[15] P. Loppnau,et al. A screening strategy for heterologous protein expression in Escherichia coli with the highest return of investment. , 2012, Protein expression and purification.
[16] Barbara Imperiali,et al. Protein Oligomerization: How and Why , 2005 .
[17] Jung-Eun Park,et al. Structure based optimization of chromen-based TNF-α converting enzyme (TACE) inhibitors on S1' pocket and their quantitative structure-activity relationship (QSAR) study. , 2010, Bioorganic & medicinal chemistry.
[18] Yan Feng,et al. Optimization of recombinant hyperthermophilic esterase production from agricultural waste using response surface methodology. , 2006, Bioresource technology.
[19] W D Luzier,et al. Materials derived from biomass/biodegradable materials. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[21] R. Locksley,et al. The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.
[22] F. Baneyx. Recombinant protein expression in Escherichia coli. , 1999, Current opinion in biotechnology.
[23] V. Sahai,et al. Enhanced expression of the recombinant lethal factor of Bacillus anthracis by Fed-Batch culture. , 2001, Biochemical and biophysical research communications.
[24] C. Nelson,et al. Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. , 2001, The Journal of clinical investigation.
[25] M. Khodabandeh,et al. Response surface methodology for optimizing the induction conditions of recombinant interferon beta during high cell density culture , 2008 .
[26] A. Corti,et al. Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels. , 1992, The Biochemical journal.
[27] A. Xu,et al. Production of a new sea anemone neurotoxin by recombinant Escherichia coli: Optimization of culture conditions using response surface methodology , 2005 .
[28] Margaret J. Robertson,et al. Design and Analysis of Experiments , 2006, Handbook of statistics.
[29] P. Szlosarek,et al. Tumour necrosis factor-α as a tumour promoter , 2006 .
[30] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[31] P. Szlosarek,et al. Tumour necrosis factor-alpha as a tumour promoter. , 2006, European journal of cancer.
[32] M. Kharrati-Kopaei,et al. Optimization of an extracellular zinc-metalloprotease (SVP2) expression in Escherichia coli BL21 (DE3) using response surface methodology. , 2012, Protein expression and purification.
[33] A. Corti,et al. Oligomeric tumour necrosis factor α slowly converts into inactive forms at bioactive levels , 1992 .
[34] Hao Sun,et al. Metabolic activation of a novel 3-substituted indole-containing TNF-alpha inhibitor: dehydrogenation and inactivation of CYP3A4. , 2008, Chemical research in toxicology.
[35] S. Singh,et al. Solubilization and refolding of bacterial inclusion body proteins. , 2005, Journal of bioscience and bioengineering.
[36] A. L. Larentis,et al. Cloning and optimization of induction conditions for mature PsaA (pneumococcal surface adhesin A) expression in Escherichia coli and recombinant protein stability during long-term storage. , 2011, Protein expression and purification.
[37] A. Poustka,et al. Large‐scale protein expression for proteome research , 2005, Proteomics.
[38] Douglas C. Montgomery,et al. Response Surface Methodology: Process and Product Optimization Using Designed Experiments , 1995 .
[39] A. Xu,et al. Functional expression and characterization of a recombinant phospholipase A2 from sea snake Lapemis hardwickii as a soluble protein in E. coli. , 2003, Toxicon : official journal of the International Society on Toxinology.
[40] D. Kioussis,et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.